Emfosik-25 Tablets

Emfosik-25 contains Empagliflozin 25 mg, an advanced SGLT2 inhibitor used for controlling blood sugar levels in adults with Type 2 Diabetes Mellitus. It works by helping the kidneys remove excess glucose from the body through urine.

Apart from lowering sugar levels, Empagliflozin is clinically proven to reduce the risk of cardiovascular death and protect kidney health in diabetic patients with heart disease.

Benefits:

• Powerful Blood Sugar Control – Lowers both fasting and post-meal glucose levels.

• Heart & Kidney Protection – Reduces cardiovascular risk and slows kidney damage progression.

• Weight & Blood Pressure Benefits – Supports healthy weight loss and lowers BP in diabetic patients.

Dosage:

Take one tablet daily in the morning, with or without food, or as prescribed by your doctor.

Why Cardiever?

• Premium Quality, GMP & ISO Certified – Guaranteed safety and efficacy.

• Trusted Cardio-Diabetic Range – Specialised expertise in heart and diabetes medicines.

• Clinically Reliable Formulation – Meets international standards for purity and potency.

• Affordable Excellence – Advanced therapy at competitive pricing for better patient access.